Publication

Idiopathic Intracranial Hypertension: Relation Between Obesity and Visual Outcomes

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Aimee J. Szewka, Emory UniversityBeau Benjamin Bruce, Emory UniversityNancy J. Newman, Emory UniversityValerie Biousse, Emory University
Language
  • English
Date
  • 2013-03
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • © 2013 by North American Neuro-Ophthalmology Society
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1070-8022
Volume
  • 33
Issue
  • 1
Start Page
  • 4
End Page
  • 8
Grant/Funding Information
  • This study was supported in part by a departmental grant (Department of Ophthalmology) from Research to Prevent Blindness, Inc., New York, by core grant P30-EY06360 (Department of Ophthalmology). Dr. Bruce receives research support from the NIH/NEI (K23-EY019341) and received the American Academy of Neurology Practice Research Fellowship. Dr. Newman is a recipient of the Research to Prevent Blindness Lew R. Wasserman Merit Award.
Abstract
  • Background Increased body mass index (BMI) has been associated with increased risk of idiopathic intracranial hypertension (IIH), but the relationship of BMI to visual outcomes in IIH is unclear. Methods A retrospective chart review of all adult cases of IIH satisfying the modified Dandy criteria seen at our institution between 1989 and 2010 was performed. Demographics, diagnostic evaluations, baseline visit and last follow-up examination data, treatment and visual outcome data were collected in a standardized fashion. Groups were compared and logistic regression was used to evaluate the relationship of BMI to severe visual loss, evaluating for interaction and controlling for potential confounders. Results Among 414 consecutive IIH patients, 158 had BMI≥40 (WHO Obese Class III), and 172 had BMI 30–39.9. Patients with BMI≥40 were more likely to have severe papilledema at first neuro-ophthalmology encounter than those with a lower BMI (p=0.02). There was a trend toward more severe visual loss in one or both eyes at last follow up among those patients with BMI≥40 (18 vs. 11%, p=0.067). Logistic regression modelling found that ten unit (kg/m2) increases in BMI increased the odds of severe visual loss by 1.4 times (95%CI: 1.03–1.91, p=0.03), after controlling for sex, race, diagnosed hypertension, and diagnosed sleep apnea. Conclusion Our finding of a trend for severe papilledema and visual loss associated with increasing BMI suggests that very obese IIH patients should be closely monitored for progression of visual field loss.
Author Notes
  • Correspondence: Nancy J. Newman, MD Neuro-ophthalmology Unit, Emory University 1365-B Clifton Rd, NE, Atlanta, GA 30322 OPHTNJN@emory.edu Tel: 404-778-5360 Fax: 404-778-4849
Keywords
Research Categories
  • Biology, Neuroscience
  • Health Sciences, Opthamology

Tools

Relations

In Collection:

Items